You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors

Article metrics

Article menu
Immunotherapy biomarkers
Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors

 

Online download statistics by month:

Online download statistics by month: March 2023 to July 2025

AbstractFullPdf
Mar 2023361369162
Apr 202315715866
May 202312412756
Jun 202317017048
Jul 2023504507127
Aug 202311912023
Sep 2023808027
Oct 2023818317
Nov 202310010038
Dec 2023737440
Jan 2024565633
Feb 2024636331
Mar 2024585863
Apr 2024545428
May 2024838338
Jun 2024444330
Jul 2024707139
Aug 2024605831
Sep 2024676726
Oct 2024646445
Nov 2024666727
Dec 2024596221
Jan 2025686937
Feb 2025545426
Mar 2025565732
Apr 2025777735
May 2025313122
Jun 2025333326
Jul 2025110
Total283328561194